Vaccine development and manufacture is one of the most challenging tasks within biopharmaceuticals today. R&D projects are characterized by technical complexity, and production processes by methods that can be both inflexible and costly. In addition, local vaccine manufacturers do not always meet international quality standards.
And when the products are finally ready for introduction, intended marketplaces are often diverse. Different national recommendations and funding may slow introduction, for example. In addition, public healthcare systems are always looking to lower the cost of treatment.
But vaccines can also be highly rewarding, and one route to success is to enlist the help of GE Healthcare. Our expertise, technology platforms, and products help drive vaccine development forward, optimizing manufacturing processes and maximizing the rewards.